The Washington Post

Pfizer to acquire Medivation for $14 billion

Pharmaceutical giant Pfizer announced Monday that it has agreed to acquire Medivation in a $14 billion deal that would add a blockbuster drug to its cancer pipeline. Medivation, a San Francisco biopharmaceutical company, has been highly sought after in recent months. Its flagship product, Xtandi, is a prostate cancer treatment that generated $2.2 billion in sales over [...]

August 22nd, 2016|The Washington Post|

Verizon’s biggest problem in acquiring Yahoo — ‘They bought David Spade’

Just about the only excitement contained in Verizon’s announcement Monday that it plans to buy Yahoo’s core business for $4.83 billion could be found in the exclamation point lodged in Yahoo!’s trademarked name. “There was a collective yawn in the industry,” said Eric Goodness, lead Verizon analyst at Gartner. Yahoo made its name 20 years [...]

July 25th, 2016|The Washington Post|

The Dow-DuPont megamerger: A deal only Wall Street could love

Two of the country’s oldest companies, Dow Chemical and DuPont, have long served as the backbone for American scientific ingenuity in the modern age. Their armies of chemical researchers are the reason soldiers wear Kevlar and homeowners buy Saran Wrap, Teflon-lined pans and Ziploc bags. Full Article Here

December 9th, 2015|The Washington Post|